The Foundation supports research across basic, translational and clinical science to speed breakthroughs that can lead to the creation of new treatments and a better quality of life for people with Parkinson's disease.
Search or browse funded studies
Previously funded studies appear chronologically, with the most recent appearing first.
-
Rapid Response Innovation Awards, 2010Increased Dopamine Transporter Function as an Early Phenotype of PD, Prior to Dopamine Neuron Cell Death
Objective/Rationale:
Since the identification of a number of Parkinson’s disease genes in humans, much effort has been spent at developing pre-clinical models of the disease. However, most genetic pre... -
Novel Hypotheses in Parkinson's Disease, 2010Gait disturbances in Parkinson's disease: new links to alpha-synuclein pathology
Objective/Rationale:
Gait disturbances in PD are characteristic of advanced Parkinson’s disease (PD); they are extremely disabling to the patient and can frequently lead to patient falls, fractures... -
Novel Hypotheses in Parkinson's Disease, 2010Identifying and Localizing Toxic Oligomeric A-Syn with Morphology Specific Nanobodies
Objective/Rationale:
Aggregation and deposition of the protein, a-synuclein (a-syn), has been strongly correlated with PD and other related neurodegenerative disorders. The a-syn protein occurs in a... -
Pharmacodynamic Biomarkers of LRRK2 Activity, 2010Determining Pharmacodynamic Biomarkers of LRRK2 Activity in Lymphocytes
Objective/Rationale:
Therapeutic strategies targeting aberrant LRRK2 activity hold great promise for the treatment of familial LRRK2 mutant and perhaps idiopathic PD. Development of pharmacodynamic... -
MJFF Research Grant, 2010Physiological and Pathological Implications of the Unique Subcellular Distribution of LRRK2
Objective/Rationale:
Mutations in the LRRK2 gene are now recognized as the most common genetic cause of Parkinson’s disease, responsible for not only several inherited forms of this movement disorder... -
MJFF Research Grant, 2010Validation of Enzymatic Activity and Neuropathology in G2019S LRRK2-induced Dopaminergic Neurodegeneration in a Pre-clinical Model of Parkinson's Disease
Objective/Rationale:
Mutations in the LRRK2 gene are a common cause of familial and sporadic Parkinson’s disease. Familial LRRK2 mutations induce neuronal toxicity in vitro. Reliable pre-clinical...
Apply for a Grant
Our funding programs support basic, translational and clinical research from academia and industry.